• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Edgewise

Edgewise Therapeutics

A Movement in Muscle

  • Clinical Trials
  • Careers
  • Investors & News
  • Menu
    • Disease Areas
    • Muscular Dystrophy
    • Hypertrophic Cardiomyopathy

    Learn more about how our science is driving a new understanding of muscle and its potential to transform human health.

    Explore Muscle

    • Science & Pipeline
    • Pipeline
    • Sevasemten
    • EDG-7500
    • Clinical Trials
    • Posters & Presentations

    All of us at Edgewise are committed to developing new medicines for people facing serious muscle diseases with unmet medical needs.

    Explore our Science

    • Patients & Families
    • Support for Becker
    • Support for Duchenne
    • Support for HCM
    • Patient Stories

    We honor the experience of individuals and families living with and facing the challenges of serious muscle disease.

    Read their Stories

    • Company
    • Leadership Team
    • Careers
    • Contact Us

    Our vision is to improve the lives of patients and families suffering from serious muscle diseases by building the world’s leading muscle-focused company.

    Learn More

    • Corporate Profile
    • News
    • Events & Presentations
    • Analyst Coverage
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
      • Investment Calculator
    • Financials
      • Quarterly Results
      • SEC Filings
    • Governance
      • Governance Documents
      • Committee Composition
    • Resources
      • Investor FAQs
      • Investor Email Alerts
      • Investor Contacts
HomeDisease Areas

Disease Areas

Dedicated Science for Serious Muscle Diseases

At Edgewise, muscle science moves us forward; its promise to solve significant unmet need in patient communities drives our research and inspires our thinking as we pursue new possibilities in therapeutic development for serious muscle diseases.

Start with the patient.
Follow the science.

Transformative science has no boundaries; it can surprise us, fascinate us, even challenge us as it overturns conventional, comfortable ways of thinking. When science starts with the core problem at the human level, it reveals fundamental truths about our world and ourselves, pointing towards new directions in our quest to bring life-changing medicines to people living with serious muscle diseases.

Muscle:  a critiCal organ with strong therapeutic potential

Muscle plays a vital role in human health. It’s an extraordinary organ that connects us to the world, powers our most essential organs, plays a key role in metabolism, regeneration, and growth, and helps us experience everyday through our senses and movement. But when the muscle, including the skeletal or cardiovascular muscle, is affected by serious disease, our bodies can be limited—in our health, our mobility, and in our ability to live to our true potential.

Our Focus:

Serious Muscle Diseases With Life-limiting Impact

All of us at Edgewise are committed to developing new medicines for people facing serious muscle diseases with unmet medical needs. Our current focus is on conditions affecting skeletal and cardiovascular muscle, including muscular dystrophies like Becker and Duchenne, and cardiovascular conditions like Hypertrophic Cardiomyopathy.

Explore our science

Cardiovascular Diseases

The most common genetic heart disease, HCM is associated with reduced quality of life and elevated risk of heart failure, abnormal heart rhythms, and sudden cardiac death.

Learn More About HCM

Muscular Dystrophy

In muscular dystrophies muscle contraction with everyday movements causes muscle injuries. Learn more about contraction-induced muscle injury and its role in disease progression.

Learn More About MD

Scientists. Physicians. Leaders.
Dedicated to Muscle Science.

Edgewise is dedicated to better understanding how complex physiologic muscle processes interact with disease pathologies in our bodies and the ways muscle plays a role in contributing to human health. We’re applying our knowledge across multiple disease states and, combined with our expertise in muscle physiology and small molecule drug design, we are making significant progress in developing new classes of muscle-targeted medicines. Our goal is to help people living with serious neuromuscular and cardiovascular diseases better manage their conditions—and live fuller, richer, and healthier lives.

Meet us

Footer

Edgewise Therapeutics
  • Disease Areas
  • Science & Pipeline
  • Patients & Families
  • Company
  • Investors & News

Deep knowledge of integrated 
muscle physiology

Learn more about how our science is driving a new understanding of muscle and its potential to transform human health.

Explore our Science

2025 © Copyright. Edgewise Therapeutics. All Rights Reserved.

  • Privacy Policy
  • Terms of Use
Facebook X, formally Twitter LinkedIn Instagram YouTube
logo
  • Disease Areas
    • Muscular Dystrophy
    • Hypertrophic Cardiomyopathy
  • Science & Pipeline
    • Pipeline
    • Sevasemten
    • EDG-7500
    • Clinical Trials
    • Posters & Presentations
  • Patients & Families
    • Support for Becker
    • Support for Duchenne
    • Support for HCM
    • Patient Stories
  • Company
    • Leadership Team
    • Careers
    • Contact Us
  • Investors & Media
    • Corporate Profile
    • News
    • Events & Presentations
    • Analyst Coverage
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
      • Investment Calculator
    • Financials
      • Quarterly Results
      • SEC Filings
    • Goverance
      • Governance Documents
      • Committee Composition
    • Resources
      • Investor FAQs
      • Investor Email Alerts
      • Investor Contacts